VIVO Cannabis Inc. V.PDA

Primary Symbol: VVCIF

Healthcare Drug Manufacturers - Specialty & Generic

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.

OTCQB:VVCIF - Post by User

VIVO Cannabis Inc.

Bullboard Posts

Comment by 1hot-techwomanon Mar 13, 2018 9:15am

126 Views

Post# 27705485

RE:RE:RE:Abcann and CBW deal...

saveyourselfnow wrote:
1hot-techwoman wrote:

saveyourselfnow wrote: The link is below - we all know about it but look at the last "bullet" point :

Anyone care to do the math? Sounds like CBW could be paying 2 times daily average of last 10 days OR $2.25...

To me - double average 10 days looks around $3.75 (just a quick guesstimate).

https://www.skanderbegcapital.com/cannabis-wheaton/abcann-global-cannabis-wheaton-sign-interim-agreement-construction-additional-cannabis-cultivation-facility/

ABcann Global Corporation (TSX.V:ABCN) (formerly Panda Capital Inc.) (“ABcann”) and Cannabis Wheaton Income Corp. (TSX.V:CBW) (“Cannabis Wheaton” or “CW”) are pleased to report that they have entered into a binding interim agreement (the “Agreement“) to fund the construction of 50,000 square feet of cultivation space (the “Expansion Production Area“) at ABcann’s proposed cannabis cultivation facility to be located in Napanee, Ontario known as the Kimmett facility (the “Facility“). Pursuant to the Agreement, Cannabis Wheaton has agreed to invest $30 million in ABcann as follows:

on the date that is the earlier of 10 days of the final closing of CW’s previously announced financing or by June 30, 2017, CW will subscribe for $15 million of ABcann common shares (each, an “ABcann Share“) at an agreed upon valuation of $2.25 per ABcann Share; and

on the date that is the earlier of 10 days of CW raising an aggregate of $150 million or March 31, 2018, CW will subscribe for an additional $15 million at a price per ABcann Share equal to the greater of two times the 10 day volume average trading price of the ABcann Shares at the relevant time or $2.25.

Last 10 days of march will not be $3.75 I can tell you that. It will be $2.25 that's why they are keeping it at this level. Don't expect much till after March 31st !

YOU are missing the important part:

CW will subscribe for an additional $15 million at a price per ABcann Share equal to the greater of two times the 10 day volume average trading price of the ABcann Shares at the relevant time or $2.25.

so yes, we are taliking DOUBLE the SP